1-2 of 2
Brian K. Nordgren
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Final Results of a Frontline Phase 1/2 Study of Carfilzomib, Lenalidomide, and Low-Dose Dexamethasone (CRd) in Multiple Myeloma (MM)

Andrzej J Jakubowiak, MD, PhD, Dominik Dytfeld, MD, PhD, Sundar Jagannath, MD, David H. Vesole, MD, PhD, Tara B. Anderson, Brian K. Nordgren, Kristen Detweiler-Short, Daniel Lebovic, MD, Keith E. Stockerl-Goldstein, MD, Kent A. Griffith, Terri L. Jobkar, BSN, Diane E Durecki, BA, Sandra M. Wear, RN, Robert F Ott, MBA, Ammar Al-Zoubi, MD, Melissa A Mietzel, M.S. CCRP, M Hussein, Daniel Couriel, MD, Joseph A Leveque, MD, Ravi Vij, MD
Journal: Blood
Blood (2011) 118 (21): 631.
https://doi.org/10.1182/blood.V118.21.631.631
Published: 2011
Journal Articles

Carfilzomib, Lenalidomide, and Dexamethasone In Newly Diagnosed Multiple Myeloma: Initial Results of Phase I/II MMRC Trial

Andrzej J Jakubowiak, MD, PhD, Dominik Dytfeld, MD, PhD, Sundar Jagannath, MD, David H. Vesole, MD, PhD, Tara B. Anderson, Brian K. Nordgren, Daniel Lebovic, MD, Keith E. Stockerl-Goldstein, MD, Kent A. Griffith, Melissa A. Hill, Colleen K. Harvey, Akari M. Dollard, Robert Ott, Susan L. Kelley, MD, Jennifer Barrickman, Michael Kauffman, MD, PhD, Ravi Vij, MD
Journal: Blood
Blood (2010) 116 (21): 862.
https://doi.org/10.1182/blood.V116.21.862.862
Published: 2010